Toshiaki Iizuka
Toshiaki Iizuka
Graduate School of Economics, University of Tokyo
Verified email at
Cited by
Cited by
Experts' agency problems: evidence from the prescription drug market in Japan
T Iizuka
The RAND Journal of Economics 38 (3), 844-862, 2007
The effect of prescription drug advertising on doctor visits
T Iizuka, GZ Jin
Journal of Economics & Management Strategy 14 (3), 701-727, 2005
Physician agency and adoption of generic pharmaceuticals
T Iizuka
American Economic Review 102 (6), 2826-58, 2012
An empirical analysis of planned obsolescence
T Iizuka
Journal of Economics & Management Strategy 16 (1), 191-226, 2007
What explains the use of direct‐to‐consumer advertising of prescription drugs?
T Iizuka
The Journal of Industrial Economics 52 (3), 349-379, 2004
Direct to consumer advertising and prescription choice
T Iizuka, GZ Jin
Journal of Industrial Economics 55 (4), 771-771, 2007
Patient cost sharing and medical expenditures for the elderly
K Fukushima, S Mizuoka, S Yamamoto, T Iizuka
Journal of Health Economics 45, 115-130, 2016
Association of the national health guidance intervention for obesity and cardiovascular risks with health outcomes among Japanese men
S Fukuma, T Iizuka, T Ikenoue, Y Tsugawa
JAMA Internal Medicine 180 (12), 1630-1637, 2020
Does higher malpractice pressure deter medical errors?
T Iizuka
The Journal of Law and Economics 56 (1), 161-188, 2013
Robots and labor in the service sector: Evidence from nursing homes
K Eggleston, YS Lee, T Iizuka
National Bureau of Economic Research, 2021
Generic entry in a regulated pharmaceutical market
T Iizuka
The Japanese Economic Review 60 (1), 63-81, 2009
The effects of direct-to-consumer advertising in the prescription drug markets
T Iizuka, GZ Jin
SSRN, 2020
False alarm? Estimating the marginal value of health signals
T Iizuka, K Nishiyama, B Chen, K Eggleston
Journal of public economics 195, 104368, 2021
Drug Advertising and Health Habit
T Iizuka, GZ Jin
National Bureau of Economic Research, 2005
The generic drug market in Japan: will it finally take off?
T Iizuka, K Kubo
Health Economics, Policy and Law 6 (03), 369-389, 2011
Promoting innovation in small markets: Evidence from the market for rare and intractable diseases
T Iizuka, G Uchida
Journal of Health Economics 54, 56-65, 2017
Is zero a special price? Evidence from child health care
T Iizuka, H Shigeoka
American Economic Journal: Applied Economics 14 (4), 381-410, 2022
The impact of physician supply on the healthcare system: evidence from Japan's new residency program
T Iizuka, Y Watanabe
Health economics 25 (11), 1433-1447, 2016
Avoidable hospital admissions from diabetes complications in Japan, Singapore, Hong Kong, and communities outside Beijing
J Quan, H Zhang, D Pang, BK Chen, JM Johnston, W Jian, ZY Lau, ...
Health Affairs 36 (11), 1896-1903, 2017
Free for children? Patient cost-sharing and healthcare utilization
T Iizuka, H Shigeoka
National Bureau of Economic Research, 2018
The system can't perform the operation now. Try again later.
Articles 1–20